Tag Archives: DEA

One Toke Over The Line, Sweet Jesus! – Update for May 17, 2024

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

DOJ PROPOSES RESCHEDULING MARIJUANA

onetoke240517If you remember Brewer & Shipley’s 1970 unlikely hit, “One Toke Over the Line” – a song conceived and written in a pot-induced fog – you were probably not there to hear it. The song became so popular that even Lawrence Welk – who reportedly didn’t know what a ‘toke’ was – had his in-house singers cover the hit on his show.

The Dept of Justice yesterday proposed changing the classification of marijuana from a Schedule I drug–that is, one with no medical use and a high potential for abuse–to a Schedule III substance–one with a moderate to low potential for physical and psychological dependence.

In a document known as a Notice of Proposed Rulemaking (NPRM), the DOJ suggests moving pot from a classification shared with heroin, MDMA and LSD, to one containing medically useful substances like Tylenol with codeine, ketamine, anabolic steroids and testosterone.

marijuanahell190918The proposed rule, to be published in the Federal Register, “recognizes the medical uses of cannabis and acknowledges it has less potential for abuse than some of the nation’s most dangerous drugs,” according to the Associated Press. A 60-day public comment period will begin after the NPRM is published, along with a review of the proposed regulatory reforms by a Drug Enforcement Administration administrative law judge. In all likelihood, a final rule will be pushed out by the Administration before the November election.

The proposal would not legalize marijuana outright for recreational use nor does it directly affect criminal statutes or people serving federal sentences for marijuana cultivation or distribution. Nevertheless, it is likely an incremental step toward making changes in marijuana Sentencing Guidelines and scheduling in the penalties sections of 21 USC 841(b)(1)(A) and (B).

The DOJ proposal comes on the heels of a Dept of Health and Human Services Department review of marijuana scheduling, begun at the urging of President Joe Biden in October 2022.

Biden posted a video on the X (formerly known as Twitter) in which he said the proposal to move pot to Schedule III constitutes “an important move towards reversing longstanding inequities.”

marijuana221111“Today’s announcement builds on the work we’ve already done to pardon a record number of federal offenses for simple possession of marijuana,” the president said. “Look, folks, no one should be in jail for merely using or possessing marijuana. Period… Far too many lives have been upended because of a failed approach to marijuana and I’m committed to righting those wrongs. You have my word on it.”

Writing in Reason, C.J. Ciaramella said

On the campaign trail in 2020, Biden promised to ‘decriminalize the use of cannabis,’ but despite lamenting the injustices of marijuana convictions and the barriers they create, and despite the continuing collapse of public support for marijuana prohibition, Biden still opposes full-scale legalization. Instead, his administration has focused on mass pardons and other measures that largely leave those injustices in place… But even getting the DEA to acknowledge that marijuana is not a drug on par with LSD and heroin is a victory of sorts.

While encouraged by the DOJ action, Cynthia W. Roseberry, director of policy and government affairs at the ACLU’s Justice Division, cautioned, “The rescheduling does not end criminal penalties for marijuana or help the people currently serving sentences for marijuana offenses. It is time for the federal government to further reduce prosecution of marijuana and instead put more resources towards investments that help communities thrive.”

Associated Press, Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift (May 16, 2024)

Reason, DEA Moves To Reclassify Marijuana as a Schedule III Drug (May 16, 2024)

ACLU, ACLU Applauds President Biden’s Announcement to Reclassify Marijuana, Calls for More Reform (May 16, 2024)

– Thomas L. Root

Feds To Reschedule Marijuana As Prescription Drug – Update for May 3, 2024

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

MARIJUANA BECOMING OFFICIALLY ‘COOL’

mrnatural240503The Justice Department last Tuesday said that it had recommended easing restrictions on marijuana in what could amount to a major change in federal policy.

A DOJ spokeswoman said the proposed rule, which hasn’t yet been made public, would downgrade marijuana from Schedule I to Schedule III, making it obtainable with a prescription.

The change does not end the criminalization of the drug. However, it is a significant shift in the government’s view of the safety and use of marijuana for medical purposes and reflects President Biden’s effort to liberalize marijuana policy in a way that puts it more in line with the public as increasingly more Americans favor legalizing the drug. The proposal would recognize the medical uses of marijuana and acknowledge it has less potential for abuse than some of the nation’s more dangerous drugs.

Rescheduling would not legalize marijuana outright for recreational use. But there can be little doubt that such a change–recreational cannabis (the politically popular term for marijuana) is now legal in 24 states–is coming.

The change may also lead to beneficial changes in Section 2D1.1 of the U.S. Sentencing Guidelines, where the base offense level for marijuana could drop in response to its falling from Schedule I to III.

In October 2022, Biden pardoned thousands of people convicted of simple marijuana possession under federal law and called upon regulators to review whether the drug should be reclassified, saying “it doesn’t make sense” that the government controls pot more tightly than cocaine or fentanyl.

marijuanahell190918Once the Office of Management and Budget signs off, the DEA will take public comment on the plan to move marijuana from its Schedule I–alongside heroin and LSD–to Schedule III, alongside ketamine and some anabolic steroids. After public comment and review by an administrative judge, the agency will publish the final rule.

“Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” DOJ Director of Public Affairs Xochitl Hinojosa said in a statement. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.”

The Los Angeles Times said, “Late last year, Biden pardoned people who were convicted of using marijuana on federal land. That tiny step was merely a down payment on his promise of decriminalization. So is the Justice Department’s most recent move. The federal government should pick up the pace.”

Some in the government may have done so. Last Wednesday, Senate Majority Leader Charles Schumer, (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR), and Sen Cory Booker (D-NJ) reintroduced the Cannabis Administration and Opportunity Act, legislation to end federal marijuana prohibition by removing it totally from the Controlled Substances Act.

The bill also aims to empower states to create their own cannabis laws; ensure federal regulations protect public health and safety; and prioritize restorative and economic justice, according to the sponsors.

marijuana221111While the DEA’s move to reclassify marijuana is a “necessary step” that’s “long overdue,” Schumer said, it’s not the end of the story. “It’s not all we need to do,” he said. “It’s time for Congress to wake up to the times and do its part by passing the cannabis reform that most Americans have wished for. It’s past time for Congress to catch up with public opinion and to catch up with the science.”

New York Times, Justice Dept. Recommends Easing Restrictions on Marijuana (April 30, 2024)

Wall Street Journal, Biden Administration Aims to Reclassify Marijuana as Less Dangerous Drug (April 30, 2024)

Associated Press, US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance (April 30, 2024)

Los Angeles Times, Editorial: Reclassifying marijuana is not decriminalization, but is a welcome step in that direction (May 1, 2024)

Cannabis Business Times, Senate Democrats Introduce Bill to Federally Legalize Cannabis (May 1, 2024)

S.4226, A bill to decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (May 1, 2024)

– Thomas L. Root

Congress Is Back In Town… Little Has Changed – Update for September 12, 2023

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

THEY’RE B-A-A-A-CK

Congress returned last week after its long August recess, ready to dig in and work on anything other than criminal justice reform.

equal220812

Last week, the right-of-center Americans For Tax Reform wrote all members of Congress urging passage of the EQUAL Act (S.524, H.R. 1062). Anti-tax advocate Grover Norquist argued that the crack/powder sentencing “unjustified disparity has resulted in the imprisonment of people who pose no greater threat than their counterparts convicted of cocaine offenses for far greater periods.”

Norquist argued that “it is a core, taxpayer-funded, government role to protect citizens from crime, and manage the criminal justice system. Taxpayers, and all Americans who cherish individual liberty, should take an interest that the criminal justice system is efficient and effective at protecting public safety, upholding the rule of law and property rights, while respecting the constitutional rights of citizens. Where there are failures, conservatives should work to fix the issue, just as we do in other areas of government.”

The Illinois Times last week reported that Sen Richard Durbin (D-IL), chair of the Judiciary Committee, said the EQUAL Act has failed to come up for a Committee vote “because of the opposition of a Republican member of the committee, whom he declined to identify.”

“One Republican wouldn’t go for 1-to-1, and we deal with consensus on the committee,” Durbin said. “I have him down lower – substantially lower than 18-to-1 – and I’m trying to get the other side that wants it to be 1-to-1 to accept a different figure. But that’s where we’ve been stuck for over a year. I’m going to do my best to get this moving.”

The unidentified Republican is undoubtedly Sen Charles Grassley (R-IA), ranking Republican on the Committee and co-sponsor with Durbin of a number of reform measures, most notably the First Step Act. Last December, Grassley’s proposal of 2.5-1 and nonretroactivity except with Dept of Justice consent in the so-called SMART Cocaine Sentencing Act (S.4116) killed EQUAL’s passage in the last Congress. Now, 9 months later, nothing seems to have changed.

Meanwhile, in the wake of last week’s recommendation by the Dept of Health and Human Services that marijuana be rescheduled from a Schedule I to a Schedule III drug, the White House last week asserted that President Biden has “always supported the legalization of marijuana for medical purposes,” she said. “He’s been very clear about that, where appropriate, consistent with medical and scientific evidence.

potscooby180713Marijuana Moment noted that “it’s not accurate to say that Biden has “always” backed cannabis reform. As a senator, he championed several pieces of legislation that ramped up the war on drugs.” Nevertheless, “if DEA goes along with HHS’s Schedule III recommendation, that would represent a major shift in federal marijuana policy, with an acknowledgment that cannabis is not a drug of high abuse potential and no medical utility.”

On the other hand, The Hill reported that advocates and policy experts say rescheduling marijuana under the Controlled Substances Act does not address the plethora of racial justice issues caused by current law.

“Rescheduling doesn’t address … the harm to marginalized communities,” said Natacha Andrews, executive director for the National Association of Black Cannabis Lawyers. “It doesn’t address the over-policing, it doesn’t address the immigration issues, it doesn’t address the access to federal services, and it’s not in alignment with what 38 states have done to regulate and legalize.”

“My initial reaction is that this is less than what the Biden administration promised specifically,” Cat Packer, director of drug markets and legal regulation at the Drug Policy Alliance, told The Hill.

MSNBC reported, “To be sure, moving marijuana to Schedule III wouldn’t dismantle the drug war or solve the host of problems needlessly caused by prohibition. Descheduling, or removing the plant from the government’s list of controlled substances, would make more sense and better align with Biden’s stated criminal justice views. Still, rescheduling would be historic, if only due to the historic stupidity that has kept cannabis on Schedule I to date.”

Americans for Tax Reform, Support for the EQUAL Act (September 8, 2023)

Illinois Times, Unjust Sentencing (September 7, 2023)

Marijuana Moment, Biden Has ‘Always Supported The Legalization Of Marijuana For Medical Purposes,’ White House Says Amid Rescheduling Recommendation (September 4, 2023)

The Hill, Marijuana rescheduling falls short of expectations on Biden (September 8, 2023)

MSNBC, What the federal ‘rescheduling’ of cannabis would (and wouldn’t) mean (September 4, 2023)

– Thomas L. Root

Biden FDA Delivers On Pot Rescheduling; Now for the DEA – Update for September 7, 2023

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

FOOD AND DRUG ADMINISTRATION PROPOSES DROPPING MARIJUANA TO SCHEDULE III

marijuana221111The Dept of Health and Human Services’ Food and Drug Administration last week recommended that the Drug Enforcement Administration significantly loosen federal restrictions on marijuana, yet stopping short of proposing that pot be removed completely from the Controlled Substances Act.

HHS Assistant Secretary Rachel Levine wrote in a letter to the DEA that the FDA wants the drug moved from Schedule I to Schedule III under the CSA. As part of the review process, an HHS spokesperson told Politico last week, “HHS conducted a scientific and medical evaluation for consideration by DEA. DEA has the final authority to schedule or reschedule a drug under the Controlled Substances Act. DEA will now initiate its review.”

President Biden rolled out new initiatives on marijuana last October, pardoning all prior federal simple possession offenses (none of whom was in federal prison at the time) and asking HHS and the Attorney General to review how marijuana is scheduled based on its medical use. While the DEA is not required to follow HHS’s recommendation, it is unlikely that the agency will buck the President, who has made this a White House priority.

Reclassification is a step short of legalizing marijuana entirely, but it would mark a critical shift away from marijuana’s status as a Schedule I substance. Schedule I includes drugs with high risk of abuse that have no legitimate purpose, like heroin, LSD and ecstasy. Schedule III substances, such as ketamine, are seen as less dangerous and can be obtained legally with a prescription.

mario170628The effect of dropping marijuana to Schedule III might be a Sentencing Commission rewrite of USSG § 2D1.1 on marijuana offenses. Changing statutory minimums for marijuana set out in 21 USC § 841(b)(1), however, would require action by Congress.

DEA review will be complete within the next year.

Bloomberg, US Health Officials Urge Moving Pot to Lower-Risk Tier (August 30, 2023)

Politico, Slightly higher times: Biden administration moves to loosen weed restrictions (August 30, 2023)

– Thomas L. Root

‘Spirit Is Willing But…’ In Federal Drug Reform – Update for August 8, 2023

We post news and comment on federal criminal justice issues, focused primarily on trial and post-conviction matters, legislative initiatives, and sentencing issues.

NOTHING HAPPENING HERE…

vacation190905If Congress does not approve a new appropriations bill by September 30, the government could shut down. But as anyone who works in or with the federal government knows, the government pretty much shuts down every year for the month of August as legislators, agency heads and government employees leave town for vacations.

This leaves a number of issues important to federal defendants hanging. Two of those are cocaine and marijuana reform.

Before leaving town for the beach, Dept of Justice officials filed comments with the U.S. Sentencing Commission urging the Commission to adopt a number of priorities for the coming year. On the equivalency of powder and crack cocaine, the DOJ urged the Commission (1) to advocate that Congress for passage of the EQUAL Act (S.524 and H.R.1062) to remedy the current disparity between treatment of powder cocaine and cocaine base; and (2) to remind sentencing courts of “their obligation, when considering [18 USC § 3553(a)] sentencing factors, to consider the pharmacological similarities between powder and crack cocaine and whether it is appropriate to impose a variance consistent with the relevant base offense level for powder cocaine.”

You may recall that last October, President Biden directed that the Dept of Health and Human Services lead an effort to reclassify marijuana as something less than a Schedule I drug. That effort includes review by the Drug Enforcement Administration.

marijuana160818Pressed by Rep. Matt Gaetz (R-FL) during a July 27 oversight hearing on DEA, DEA Administrator Anne Milgram told the subcommittee that the agency has not been provided with a definite timeline to review marijuana’s classification. When Gaetz asked Milgram if she would request the timeline from the HHS, she said, “I will ask.”

The rescheduling of marijuana probably won’t be done until late next year. A rescheduling could possibly lead to changes in 21 USC § 841 as to punishment – if not conviction ¬– for marijuana.

DOJ, Letter to Sentencing Commission (July 31, 2023)

Forbes, DEA Head Pledges To Seek Federal Marijuana Rescheduling Review Timeline From HHS (July 31, 2023)

House Subcommittee on Crime and Federal Government Surveillance, Hearing (July 27, 2023)

– Thomas L. Root